If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £238.70m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

TSG Consideration

23 Mar 2018 07:00

RNS Number : 6834I
Science Group PLC
23 March 2018
 

23 March 2018

 

Science Group plc

(the "Company")

 

TSG Consideration

 

 

Science Group plc acquired Technology Sciences Group ("TSG") in September 2017. The acquisition consideration included a deferred payment of $750,000 payable in December 2019, contingent on a single criterion related to the continued employment of the former Chief Executive Officer of TSG by the Vendor. The Vendor has now advised Science Group that this condition will not be satisfied and therefore the Vendor will not be entitled to receive the deferred payment.

 

The final consideration for the acquisition of TSG therefore totals $17.0 million, equivalent to approx. £13.2 million. Cash of approx. £2.8 million was acquired with the transaction, resulting in a cash outflow of £10.4 million. For the period from September to December 2017, restructuring and one-off costs of £0.8 million were incurred and TSG contributed £4.9 million revenue.

 

Correction

It has come to the Company's attention that in Note 14 of the announcement of 28 February 2018 titled "Audited results for the year ended 31 December 2017", the US dollar consideration payable for TSG was incorrectly stated (the sterling amounts were correctly stated). The figures of $17.0 million and $16.2 million should instead have been $17.8 million and $17.0 million, respectively. The corrected sentence reads:

 

The consideration of £13.7 million ($17.8 million) was satisfied by £13.2 million ($17.0 million) in cash on completion and £0.5 million ($0.8 million) as contingent consideration.

 

The Annual Report (Note 22) is correct due to the error being amended prior to printing.

 

 

- Ends -

 

For further information:

Science Group plc

Martyn Ratcliffe, Chairman

Tel: +44 (0) 1223 875 200

Rebecca Archer, Finance Director

www.sciencegroup.com

 

Numis Securities Limited

Nominated Adviser: Paul Gillam / Simon Willis

Corporate Broking: Michael Burke

Tel: +44 (0) 20 7260 1000

 

 

Notes:

 

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulations

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLFFEIVTIFFIT
Date   Source Headline
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:02 amRNSHolding(s) in Company
20th Mar 20267:01 amRNSChair Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:01 amRNSAudited Results for Year Ended 31 December 2025
17th Mar 20267:01 amRNSAudited Results for Year Ended 31 December 2025
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20262:15 pmRNSNotice of Preliminary Results
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTotal Voting Rights
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.